India’s recommends, a locally developed coronavirus vaccine called Covaxin

India’s drugs regulator has recommended for emergency use, a locally developed coronavirus vaccine called Covaxin.

Covaxin is expected to be a backup to the AstraZeneca/Oxford shot.

Covaxin has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Research (ICMR).

Not much is known about the safety and efficacy of Covaxin.

The company says it has submitted all data to the drugs regulator.